camcevi
accord healthcare s.l.u. - leuprorelin mesilate - nowotwory stercza - terapia endokrynologiczna - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
yselty
theramex ireland limited - linzagolix choline - leiomyoma - hormony przysadki i podwzgórza i ich analogi - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
coxydyna 30 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - etoricoxibum - tabletki powlekane - 30 mg
coxydyna 60 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - etoricoxibum - tabletki powlekane - 60 mg
coxydyna 90 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - etoricoxibum - tabletki powlekane - 90 mg
coxydyna 120 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - etoricoxibum - tabletki powlekane - 120 mg
feiba nf 2500 j. (2500 j. feiba) proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
takeda pharma sp. z o.o. - białko osocza ludzkiego - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 2500 j. (2500 j. feiba)
orserdu
stemline therapeutics b.v. - elacestrant - nowotwory piersi - terapia endokrynologiczna - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
lodotra 1 mg tabletki o zmodyfikowanym uwalnianiu 1 mg tabletki o zmodyfikowanym uwalnianiu
norpharma a/s - prednisonum - tabletki o zmodyfikowanym uwalnianiu - 1 mg
lodotra 2 mg tabletki o zmodyfikowanym uwalnianiu 2 mg tabletki o zmodyfikowanym uwalnianiu
norpharma a/s - prednisonum - tabletki o zmodyfikowanym uwalnianiu - 2 mg